Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Larson

Showing results (311-320 of 326) with videos related to

Pageof 33
Sort By:
Antimicrobial Agents and Chemotherapy|October 3, 2007
Activity of a potent hepatitis C virus polymerase inhibitor in the chimpanzee modelChih-Ming Chen, Yupeng He, Liangjun Lu, et al.
Bioorganic & Medicinal Chemistry Letters|July 5, 2008
Hepatitis C NS5B polymerase inhibitors: 4,4-Dialkyl-1-hydroxy-3-oxo-3,4-dihydronaphthalene-3-yl benzothiadiazine derivativesDouglas K Hutchinson, Teresa Rosenberg, Larry L Klein, et al.
Clinical Pharmacology and Therapeutics|November 5, 2010
Dipeptidyl peptidase-4 inhibitors administered in combination with metformin result in an additive increase in the plasma concentration of active GLP-1E M Migoya, R Bergeron, J L Miller, et al.
Journal for Immunotherapy of Cancer|March 14, 2023
Preclinical proof of concept for VivoVec, a lentiviral-based platform for in vivo CAR T-cell engineeringKathryn R Michels, Alyssa Sheih, Susana A Hernandez, et al.
Leukemia|November 30, 2019
IgM AL amyloidosis: delineating disease biology and outcomes with clinical, genomic and bone marrow morphological featuresSurbhi Sidana, Daniel P Larson, Patricia T Greipp, et al.
Journal of Medicinal Chemistry|March 7, 2003
Nonsteroidal selective glucocorticoid modulators: the effect of C-10 substitution on receptor selectivity and functional potency of 5-allyl-2,5-dihydro-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinolinesPhilip R Kym, Michael E Kort, Michael J Coghlan, et al.
PLOS Global Public Health|April 29, 2024
Prediction models for post-discharge mortality among under-five children with suspected sepsis in Uganda: A multicohort analysisMatthew O Wiens, Vuong Nguyen, Jeffrey N Bone, et al.
Blood|January 28, 2022
Targeting cancer-associated fibroblasts in the bone marrow prevents resistance to CART-cell therapy in multiple myelomaReona Sakemura, Mehrdad Hefazi, Elizabeth L Siegler, et al.
Blood|June 11, 2024
In vivo CAR T-cell generation in nonhuman primates using lentiviral vectors displaying a multidomain fusion ligandChristopher J Nicolai, Maura H Parker, Jim Qin, et al.
Cell Host & Microbe|June 16, 2017
Antigen Availability Shapes T Cell Differentiation and Function during TuberculosisAlbanus O Moguche, Munyaradzi Musvosvi, Adam Penn-Nicholson, et al.
Pageof 33

Showing results (311-320 of 326) with videos related to

Sort By:
Pageof 33
Antimicrobial Agents and Chemotherapy|October 3, 2007
Activity of a potent hepatitis C virus polymerase inhibitor in the chimpanzee modelChih-Ming Chen, Yupeng He, Liangjun Lu, et al.
Bioorganic & Medicinal Chemistry Letters|July 5, 2008
Hepatitis C NS5B polymerase inhibitors: 4,4-Dialkyl-1-hydroxy-3-oxo-3,4-dihydronaphthalene-3-yl benzothiadiazine derivativesDouglas K Hutchinson, Teresa Rosenberg, Larry L Klein, et al.
Clinical Pharmacology and Therapeutics|November 5, 2010
Dipeptidyl peptidase-4 inhibitors administered in combination with metformin result in an additive increase in the plasma concentration of active GLP-1E M Migoya, R Bergeron, J L Miller, et al.
Journal for Immunotherapy of Cancer|March 14, 2023
Preclinical proof of concept for VivoVec, a lentiviral-based platform for in vivo CAR T-cell engineeringKathryn R Michels, Alyssa Sheih, Susana A Hernandez, et al.
Leukemia|November 30, 2019
IgM AL amyloidosis: delineating disease biology and outcomes with clinical, genomic and bone marrow morphological featuresSurbhi Sidana, Daniel P Larson, Patricia T Greipp, et al.
Journal of Medicinal Chemistry|March 7, 2003
Nonsteroidal selective glucocorticoid modulators: the effect of C-10 substitution on receptor selectivity and functional potency of 5-allyl-2,5-dihydro-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinolinesPhilip R Kym, Michael E Kort, Michael J Coghlan, et al.
PLOS Global Public Health|April 29, 2024
Prediction models for post-discharge mortality among under-five children with suspected sepsis in Uganda: A multicohort analysisMatthew O Wiens, Vuong Nguyen, Jeffrey N Bone, et al.
Blood|January 28, 2022
Targeting cancer-associated fibroblasts in the bone marrow prevents resistance to CART-cell therapy in multiple myelomaReona Sakemura, Mehrdad Hefazi, Elizabeth L Siegler, et al.
Blood|June 11, 2024
In vivo CAR T-cell generation in nonhuman primates using lentiviral vectors displaying a multidomain fusion ligandChristopher J Nicolai, Maura H Parker, Jim Qin, et al.
Cell Host & Microbe|June 16, 2017
Antigen Availability Shapes T Cell Differentiation and Function during TuberculosisAlbanus O Moguche, Munyaradzi Musvosvi, Adam Penn-Nicholson, et al.
Pageof 33